POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients

NCT01319864 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Relapsed/Refractory AML
Relapsed/Refractory ALL
Secondary AML/MDS
Acute Leukemia of Ambiguous Lineage
AML
ALL

Interventions

DRUG: Plerixafor Dose Escalation

Sponsor

Seattle Children's Hospital

Collaborators

[object Object]
[object Object]